Validation of an HPLC method for analysis of nifedipine residues on stainless-steel surfaces in the manufacture of pharmaceuticals

• Autorzy: Milenović D. M. , Lazić M. L. , Veljković V. B. , Todorović Z. B.
• Języki publikacji: EN

Abstrakty

EN

A simple, sensitive, and convenient HPLC method has been developed, validated, and applied to analysis of nifedipine residues on the stainless-steel surfaces of equipment used in drug manufacture. Cotton swabs moistened with methanol were used to remove residues of the drug from the surfaces; recoveries were 82.26, 86.88, and 88.95% for 25, 125, and 250 µg per swab. The precision of the results, as relative standard deviation (RSD), was <5%. The method was validated over the concentration range 3-50 µg mL^-1. Small quantities of residues of the drug and its main impurities were determined by HPLC on an ODS column with methanol-water-phosphate buffer (pH 3; 0.05 M)-sodium heptanesulfonate 65:35:3:0.13 (v/v/v/w) as mobile phase at a flow rate of 0.8 mL min^-1. Detection was at 235 nm.

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2008
• Tom: Vol. 20, no. 2
• Strony: 183--194
• Opis fizyczny: Bibliogr. 45 poz., tab., rys.

Twórcy

autor

Milenović D. M.

autor

Lazić M. L.

autor

Veljković V. B.

autor

Todorović Z. B.

• Zdravlje-Actavis Company Leskovac Serbia University of Niš Faculty of Technology, Leskovac Serbia,

Bibliografia

• [1] Guide to Inspections Validation of Cleaning Processes, US Food and Drug Administration, (FDA), Office of Regulatory Affairs, Washington, DC, pp 1–6; available at: http://www.fda.gov/ora/inspect_ref/igs/valid.html (20/05/2008)
• [2] Guidance on aspects of cleaning validation in active pharmaceutical ingredient plants, Active Pharmaceutical Ingredients Committee (APIC), pp 1–56, available at: http://apic.cefic.org/pub/pub-cleaning-validation.pdf (20/05/2008)
• [3] J.S. Grundy, R. Kherani, and R.T. Foster, J. Pharm. Biomed. Anal., 12, 1529 (1994)
• [4] N. Beaulieu, N.M. Curran, S.J. Graham, R.W. Sears, E.G. Lovering, J. Liq. Chromatogr., 14, 1173 (1991)
• [5] L. Bing, H. Defu, and L. Fei, Yaowu Fenxi Zazhi, 24, 485 (2004)
• [6] C. Jianhui, D. Shuhai, and W. Hongshui, Zhongguo Yiyao Gongye Zazhy, 35, 39 (2004)
• [7] W. Zhongyan, T. Xing, H. Jinggang, P. Chunming, and W. Xiaojun, Shenyang Yaoke Daxue Xuebao, 19, 38 (2002)
• [8] P.Y. Patel, P. Suvarna, I.C. Bhoir, and M. Sundaresa, J. Chromatogr. A, 828, 283– 286 (1998)
• [9] Y. Xing and J. Wang, Zhongguo Hua Xue Hui, 17, 308–309 (1999)
• [10] S.V. Erram and H.P. Tipnis, Indian Drugs, 29, 436–438 (1992)
• [11] H.L. Rau, A.R. Aroor, and P.G. Rao, Indian Drugs 28, 283–284 (1991)
• [12] G.R. Rao, S. Raghuveer, and C.M.R. Srivastava, Indian Drugs, 22, 435–435 (1985)
• [13] H.S. Abou-Auda, T.A. Najjar, K. Al-Khamis, B.M. Al-Hadiya, N.M. Ghilzai, and N.F. Al-Fawzan, J. Pharm. Biomed. Anal., 22, 241–249 (2000)
• [14] K. Javidnia, R. Miri, and A. Jamalian, J. Pharm. Biomed. Anal., 40, 438–442 (2006)
• [15] I. Niopas and A.C. Daftsios, J. Pharm. Biomed. Anal., 32, 1213–1218 (2003)
• [16] Z. Li, M. Zhong, X. Shi, and Z. Li, Zhongguo Linchuang Yaoxue Zazhi, 14, 115– 117 (2005)
• [17] M. Zaater, E. Hasan, and N. Najib, Polish J. Pharmacol., 52, 307–312 (2000)
• [18] Q. Ge, H. Wang, Z. Zhou, M. Fu, and G. Liu, Zhongguo Yiyao Gongye Zazhi, 31, 31–33 (2000)
• [19] M.K. Qato and F.A. Mahammed, S.T.P. Pharm. Sci., 9, 203–210 (1999)
• [20] A. Goldnik, M. Gajewska, D. Marszalek, and M. Przyzycki, Acta Pol. Pharm., 53, 7–8 (1996)
• [21] Y.M. El-Sayed, E.M. Niazy, and S.H. Khidr, J. Clin. Pharm. Ther., 18, 325–330 (1993)
• [22] M.V. Vertzoni, C. Reppas, and H.A. Archontaki, Anal. Chim. Acta, 573, 298–304 (2006)
• [23] J.S. Grundy, R. Kherani, and R. Foster, J. Chromatogr. B, 654, 146–151 (1994)
• [24] Y. Guo, J. Dai, G. Qian, N. Guo, Z. Ma, and X. Guo, Int. J. Pharm., 341, 91–96 (2007)
• [25] M. Yritia, P. Parra, E. Iglesias, and J.M. Barbanoj, J. Chromatogr. A, 870, 115–119 (2000)
• [26] P. Thongnopnua and K. Viwatwongsa, J. Pharm. Biomed. Anal., 12, 119–125 (1994)
• [27] A. Jankowski and H. Lamparczyk, J. Chromatogr. A, 668, 469–473 (1994)
• [28] X.D. Wang, J.L. Li, Y. Lu, X. Chen, M. Huang, B. Chowbay, and S. Zhou, J. Chromatogr. B, 852, 534–544 (2007)
• [29] D. Zendelovska, S. Simeska, O. Sibinovska, E. Kostova, K. Miloševska, K. Jakovski, E. Jovanovska, I. Kikerkov, J. Trojačanec, and D. Zafirov, J. Chromatogr. B, 839, 85–88 (2006)
• [30] D. Xia, B. Liu, M. Yan, E. Sui, and L. Chen, Shenyang Yaoxueyuan Xuebao, 11, 130–132 (1994)
• [31] C. Liu and G. Chen, Yaowu Fenxi Zazhi, 13, 314–317 (1993)
• [32] N. Ioannis and C.D. Athanasios, J. Pharm. Biomed. Anal., 32, 1213–1218 (2003)
• [33] R. Klinkerberg, B. Streel, and A. Ceccato, J. Pharm. Biomed. Anal., 32, 345–352 (2003)
• [34] T.T. Fazio, A.K. Singh, E.R.M. Kedor–Hackmann, and M.I.R.M. Santoro, J. Pharm. Biomed. Anal., 43, 1495–1498 (2007)
• [35] T. Mirza, M.J. Lunn, F.J. Keeley, R.C. George, and J.R. Bodenmiller, J. Pharm. Biomed. Anal., 19, 747–756 (1999)
• [36] M.J. Nozal, J.L. Bernal, J.J. Jimenez, M.T. Martin, and F.J. Diez, J. Chromatogr. A, 1024, 115–122 (2004)
• [37] M.J. Nozal, J.L. Bernal, L. Toribio, M.T. Martin, and F.J. Diez, J. Pharm. Biomed. Anal., 30, 285–291 (2002)
• [38] M.J. Nozal, J.L. Bernal, L. Toribio, M.T. Martin, and F.J. Diez, J. Chromatogr. A, 919, 87–93
• [39] M.J. Nozal, J.L. Bernal, L. Toribio, J.J. Jimenez, and M.T. Martın, J. Chromatogr. A, 870, 69–75 (2000)
• [40] J. Lambropoulos, G.A. Spanos, and N.V. Lazaridis, J. Pharm. Biomed. Anal., 23, 421–428 (2000)
• [42] M.B. Boca, Z. Apostolides, and E. Pretorius, J. Pharm. Biomed. Anal., 37, 461–468 (2005)
• [43] P. Sajonz, T.K. Natishan, Y. Wu, N.T. McGachy, and D. DeTora, J. Liq. Chromatogr. Related Technol., 28, 713–725 (2005)
• [44] A.H. Schmidt, J. Liq. Chromatogr. Related Technol., 29, 1663–1673 (2006)
• [45] International Conference on Harmonization Q2 (R1): Validation of Analytical Procedures: Text and Methodology, available at: http://www.ich.org/cache/ compo/276-254-1.html (20/05/2008).